Threatened Miscarriage Clinical Trial
Official title:
Vaginal Progesterone for Treatment of Threatened Miscarriage; Randomized Clinical Trial
The purpose of the study is to assess the efficacy of vaginal micronized progesterone in the treatment of threatened miscarriage. All eligible pregnant women will be randomized to either receive vaginal progesterone or no treatment.Evaluation will be two weeks after intervention, then every 4 weeks up to 28 weeks gestation or termination of pregnancy.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02633878 -
Chinese Herbal Medicine and Micronized Progesterone for Live Births in Threatened Miscarriage
|
Phase 2 | |
| Completed |
NCT03309735 -
Non-interventional Study of Therapy for Threatened Miscarriage
|
N/A | |
| Completed |
NCT03358940 -
Assessment of Non-medical Use of Misoprostol in Case of Miscarriage or Threatened Miscarriage.
|
N/A | |
| Completed |
NCT06011057 -
Evaluation of Serum Levels of C Reactive Protein (CRP) and Its Correlation With Fetal Ultrasound Parameters in the Prediction of Threatened Miscarriage in the First Trimester
|